Ignite Creation Date:
2024-05-05 @ 5:36 PM
Last Modification Date:
2024-10-26 @ 9:34 AM
Study NCT ID:
NCT00496366
Status:
TERMINATED
Last Update Posted:
2017-03-21
First Post:
2007-07-03
Brief Title:
Capecitabine Xeloda and Lapatinib Tykerb as First-line Therapy in HER2Neu-positive Breast Cancer
Sponsor:
Rutgers The State University of New Jersey
Organization:
Rutgers The State University of New Jersey
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-07-23
Start Date Type:
ACTUAL
Primary Completion Date:
2009-12-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-03-20
Completion Date Type:
ACTUAL
First Submit Date:
2007-07-03
First Submit QC Date:
July 3 2007
Study First Post Date:
2007-07-04
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2017-03-21
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-03-20
Last Update Post Date:
2017-03-21
Last Update Post Date Type:
ACTUAL